Piramal Pharma Ltd logo

Piramal Pharma Ltd

NSE: PPLPHARMA BSE: 543635

₹237.76

+4.07 (1.74%)

Sat, 07 Nov 2026, 06:57 pm

mtf coin illustrationMTF 5xInvest in Piramal Pharma Ltd with 5x LeverageBuy with MTFpremium button ring illustration
Market Cap (in Cr)31133.58
PE Ratio0
Dividend0.06
Health TechnologyHealth Technology
Pharmaceuticals: MajorPharmaceuticals: Major
24.5K24.5K

Piramal Pharma Share Price Live Chart

1 Day

+4.07 (1.74%)

No Result Found

Summary

  • Market Cap (in Cr)

    31792.59

  • Net Profit (in Cr)

    -325.94

  • P/B

    2.22

  • Sector P/E

    38.43

  • P/E

    0

  • EV/EBITDA

    22.65

  • Debt/Equity (Industry)

    0.19

  • Interest Cover (Industry)

    10.20

  • ROCE (Industry)

    7.47

  • RONW (Industry)

    6.26

  • ROE

    -3.83

  • ROCE

    2.48

  • Debt/Equity

    0.65

  • EPS (TTM)

    0

  • Dividend Yield

    0

  • Book Value

    61.18

  • Interest Cover

    0.99

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersSEPT 2026JUN 2026MAR 2026DEC 2025SEPT 2025
Promoters34.8034.8034.8634.8634.86
FII13.6512.5230.1829.6630.27
DII14.4414.5715.6115.6914.89
Public37.1138.1119.3519.8019.98
Government0.000.000.000.000.00

Read More

Technical Analysis

RSI

69.82

MACD

9.86

50 DMA

210.48

200 DMA

178.68

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic331.27276.29257.60221.31202.62166.33111.35
Fibonacci276.29255.29242.31221.31200.31187.33166.33
Camarilla254.03248.99243.95221.31233.87228.83223.79

Pivots Level: Classic

R3

+109.96

331.27

R2

+54.98

276.29

R1

+36.29

257.60

221.31
221.31
Pivot Point
LTP: 239.32

S1

-18.69

202.62

S2

-54.98

166.33

S3

-109.96

111.35

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    228.98

  • 20-EMA

    219.50

  • 30-EMA

    215.12

  • 50-EMA

    210.08

  • 100-EMA

    200.57

  • 200-EMA

    191.63

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
27 Oct 2026board-meetingsQuarterly Results
03 Jul 2026agm
28 Apr 2026board-meetingsAccounts, Quarterly Results
28 Jan 2026board-meetingsQuarterly Results
05 Nov 2025board-meetingsQuarterly Results, Half Yearly Results
16 Jun 2025dividendFinal Dividend - Rs. - 0.1416 Jul 2025
13 Jun 2025agm
14 May 2025dividend₹0.14 Dividend /Share16 Jul 2025
12 Jun 2024dividendFinal Dividend - Rs. - 0.1112 Jul 2024
11 Jun 2024agm

Read More

Peer Comparison

Piramal Pharma Ltd logo

Piramal Pharma Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Laurus Labs Ltd logo

Laurus Labs Ltd

Zydus Lifesciences Ltd logo

Zydus Lifesciences Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Read More

Piramal Pharma Ltd About

Piramal Pharma perates as a pharmaceutical company. The Company manufactures and develops a wide range of pharmaceutical solutions to reduce diseases.

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

2020

Headquarters

CEO

Nandini Piramal

Employees

Contact

Website icon

Website

http://www.piramalpharma.com

Email icon

Email

corporate.secretarial@piramal.com

Phone icon

Phone

Location icon

Location

Ananta Bldg Piramal Corporate, Park LBS Marg Kurla west, Mumbai, Maharashtra, 400070

Read More

Piramal Pharma Ltd Company History

YearHistory
2020
  • The company was incorporated on March 4, 2020 at Mumbai as a public limited company.
  • The company acquired the pharmaceutical business from PEL.
  • The company received a 20% Strategic Growth Investment by Carlyle.
  • The company increased its stake to 100% in CCPL.
  • Piramal Pharma and Navin Fluorine mutually agreed on Piramal increasing its stake to 100% in Convergence Chemicals.
  • Piramal Pharma Solutions collaborated with Epirium Bio on an exclusive integrated development and manufacturing program for orphan drugs.
  • Piramal Pharma Solutions announced an integrated development program with Bolt Biotherapeutics for immune-stimulating antibody conjugates and sterile fill-finish.
  • Piramal Critical Care announced a strategic partnership with US-based pharmaceutical outsourcing facility Medivant Healthcare.
2021
  • The company acquired HPPL.
  • Piramal Pharma Solutions announced the winner of its Inaugural Award for Excellence in Patient Centricity.
  • Piramal Pharma Solutions entered into a Master Services Agreement with Plus Therapeutics, Inc.
  • Piramal Pharma Limited's Consumer Products Division launched 'i-feel'.
2022
  • The company acquired a minority stake in Yapan Bio Private Limited.
  • The Composite Scheme of Arrangement was sanctioned by the NCLT on August 12, 2022.
  • Piramal Pharma Solutions announced the winner of its September 2022 Award for Excellence in Patient Centricity.
  • Piramal Pharma Solutions launched ADCelerate, a rapid, integrated approach to taking ADCs to IND.
  • Piramal Pharma Solutions held the grand opening ceremony for its new API plant at Aurora, Canada manufacturing site.
  • Piramal Pharma Solutions' new API plant in Canada went online and initial production runs were successfully completed.
2023
  • The company issued rights shares of Rs. 10 in the ratio of 5:46 at a premium of Rs. 71 per share.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
GRAVITON RESEARCH CAPITAL LLPbulkBuy6856958219.720 Feb 2025
GRAVITON RESEARCH CAPITAL LLPbulkSell6856958219.8820 Feb 2025
EAST BRIDGE CAPITAL MASTER FUND LIMITEDblockSell33643099102.831 Oct 2023
EAST BRIDGE CAPITAL MASTER FUND I LIMITEDbulkBuy33643099102.831 Oct 2023
EAST BRIDGE CAPITAL MASTER FUND LIMITEDbulkSell33643099102.831 Oct 2023
EAST BRIDGE CAPITAL MASTER FUND I LIMITEDblockBuy33643099102.831 Oct 2023
CAISSE DE DEPOT ET PLACEMENT DU QUEBECbulkSell1057046694.4816 Jun 2023
THE VANGUARD GROUP INC AC VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUNDbulkBuy620291294.7116 Jun 2023
ISHARES CORE EMERGING MARKETS MAURITIUS COblockSell4050700166.9503 Nov 2022
ISHARES CORE MSCI EMERGING MARKETS ETFblockBuy4050700166.9503 Nov 2022

Read More

Piramal Pharma Ltd News

Piramal Pharma to host investor meets in Nov

Piramal Pharma Limited will hold institutional investor meetings on November 17 and 18, 2026, in Mumbai, arranged by Avendus Spark and JM Financial.

30 Oct 2026

companies

Piramal Pharma Q2FY27 Results

Piramal Pharma Ltd reported a consolidated net profit of ₹5.03 crore in Q2FY27, turning profitable from a loss last year. Revenue rose 28% YoY to ₹2,617 crore.

27 Oct 2026

companies

Piramal Pharma to host Q2FY27 earnings call on Oct 28

Piramal Pharma Limited will conduct an investor conference call on October 28, 2026, to discuss its Q2 and H1 FY2027 financial results. The session begins at 10:00 am IST.

16 Oct 2026

companies

Piramal Pharma's Bayer sales deal ends December 31, 2026

Piramal Pharma's sales agreement with Bayer Pharmaceuticals will not be renewed and is set to expire on December 31, 2026.

01 Oct 2026

companies

Piramal Pharma gets ₹4.06 Cr GST demand

Piramal Pharma received a GST demand of ₹4.06 crore plus equivalent penalty for FY21-FY23. The company intends to appeal, citing a meritorious case.

29 Sept 2026

companies

Read More

Frequently Asked Questions

  • 1.What is the stock price of Piramal Pharma Ltd?

    As of 08/11/2026 at 12:27 AM, Piramal Pharma Ltd shares are trading at ₹237.76.

  • 2.What is the market cap. of Piramal Pharma Ltd?

    As of 08/11/2026, the market capitalization of Piramal Pharma Ltd is ₹31,133.58 crore.

  • 3.When was Piramal Pharma Ltd founded?

    Piramal Pharma Ltd was founded in 2020.

  • 4.How can I buy shares of Piramal Pharma Ltd?

    You can buy shares of Piramal Pharma Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.

  • 5.What is the shareholding pattern of Piramal Pharma Ltd?

    As of September,2026, promoters hold 34.80% in Piramal Pharma Ltd, while FIIs, DIIs and public shareholders hold 13.65%, 14.44% and 37.11%, respectively. The government holds 0.00%.

  • 6.Does Piramal Pharma Ltd pay dividends?

    Yes, Piramal Pharma Ltd pays dividends to eligible shareholders. The latest dividend announced by the company was ₹Final Dividend - Rs. - 0.14 per share.

  • 7.What is the dividend yield of Piramal Pharma Ltd?

    As of 08 November, 2026, the dividend yield of Piramal Pharma Ltd stands at 0.06%.

  • 8.What are the latest financial results of Piramal Pharma Ltd?

    For the financial year ended March 2025, Piramal Pharma Ltd reported revenue of ₹9,146.00 crore and a net profit of ₹91.13 crore.

  • 9.What is the Stock symbol of Piramal Pharma Ltd?

    PPLPHARMA is the stock symbol of Piramal Pharma Ltd.

  • 10.Who is the CEO of Piramal Pharma Ltd?

    The CEO of Piramal Pharma Ltd is Nandini Piramal.

pocketful logo lightpocketful logo dark
PricingBecome a Partner
search icon
/

No results for ''

Popular search

  • popular search iconSuzlon Energy Ltd
  • popular search iconIndian Railway Finance Corporation Ltd
  • popular search iconTata Motors Ltd
  • popular search iconTata Steel Ltd
  • popular search iconRail Vikas Nigam Ltd

Recent search

      Log In
      search icon

      No results for ‘’

        Popular search

        • popular search iconSuzlon Energy Ltd
        • popular search iconIndian Railway Finance Corporation Ltd
        • popular search iconTata Motors Ltd
        • popular search iconTata Steel Ltd
        • popular search iconRail Vikas Nigam Ltd
        • popular search iconReliance Industries Ltd
        pocketful logo lightpocketful logo dark
        • Pricing
        • Become a Partner
        Log In
        • home icon
        • arrow iconstocks
        • arrow iconpiramal pharma ltd
        • Overview
        • Financials
        • Ratios
        • shareholding
        • Technical Analysis
        • Corporate Actions
        • Peer Comparison
        • About
        • Company History
        • Deals
        • News
        • FAQs

        Open Your Free Demat Account Now!

        Step into a world of zero fees and limitless opportunities!

        pocketful logo
        • Quick Links

          • Open Demat Account
          • Pocketful Web
          • Pocketful App
          • Pricing
          • Authorised Person
          • Pocketful Calculators
          • Compliance Links
        • Pages

          • Tools
          • Blogs
          • ETF Screener
          • IPO
          • ETF
          • Bonds
          • Index Heat Map
        • Products

          • Stocks
          • Commodity
          • Subscription
          • Free Stock Screener
          • Pocketful GPT
          • MTF
          • Mutual Funds
        • Company

          • About us
          • Contact us
          • Terms and Conditions
          • Policies & Procedures
          • Privacy Policy
          • Disclosure
          • Careers
        • Socials

          • Facebook iconFacebook
          • Twitter iconTwitter
          • Instagram iconInstagram
          • LinkedIn iconLinkedIn
          • Youtube iconYoutube

        2022-25 Pocketful. All rights reserved, Built with in India

        Version -5.76

        app image 1app image 2

        Stocks:

        AllABCDEFGHIJKLMNOPQRSTUVWXYZ

        Explore

        Calculators
        Popular Calculators
        Group Stocks
        Asset Management Companies
        Popular Stocks
        Indian Indices
        Sector Wise Stocks
        IPO
        Share Market
        Best MF Schemes
        Platforms
        Resources
        Gold Rates in Top Cities
        Silver Rates in Top Cities

        Others:

        NSEBSECDSLNSDLSEBIMCXMSEINCDEXNSE IFSCINDIA INXAccount Closure FormDP Investor CharterBroker Investor Charter

        Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800